Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial

NCT03052998 is registered in ClinicalTrials.gov with Robert Colebunders as lead sponsor.

NCT NCT03052998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03052998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial
Lead sponsor
Robert Colebunders
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2017
Completion date
August 1, 2018
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, ivermectin, onchocerciasis